Nucleic Acid Controls
Seracare Life Sciences Inc Seraseq ctDNA Mutation Mix v2 WT | 1 x 25 µL
To overcome the lack of patient-like reference materials for liquid biopsy, including drawbacks of existing methodologies such as sonication, SeraCare has developed a breakthrough technology that produces the most patient-like materials compared to native ctDNA. The Seraseq ctDNA Mutation Mix v2 is a highly multiplexed product for NGS-based ctDNA assays targeting cancer-relevant somatic mutations. This specific ctDNA Mutation Mix v2 product it the wild-type with an allele frequency of 0%.
Seracare Life Sciences Inc Seraseq Fusion RNA Mix v4 | 1 x 25 µL
As diagnostic testing for chromosomal translocations and other complex structural variants continues to shift from single-site methods such as Fluorescent In Situ Hybridization (FISH) and targeted reverse transcription PCR (RT-PCR) to highly multiplexed next-generation sequencing (NGS) assays, there is an increasing need for highly multiplexed reference materials covering such mutations which may be rare or difficult to obtain. SeraCare continues to innovate to address this critical market need with an updated version designed for use with NGS assays that detect gene fusions via sequencing of RNA transcripts.
